WolverHeme Happy Hour

35 Folgen

1. Dex and the Cytokine City: Managing CRS with Bispecifics

   Vom: 7.4.2025
2. LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

   Vom: 11.3.2025
3. Episode 32: Navigating a BlinatumoMAD World

   Vom: 21.1.2025
4. The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple Myeloma

   Vom: 15.1.2025
5. Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates

   Vom: 24.12.2024
6. A Bunch of ASHholes Discuss Myeloma Abstracts

   Vom: 16.11.2024
7. Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma

   Vom: 8.11.2024
8. Episode 27: Mantle Cell Masterclass with Tycel Phillips

   Vom: 10.10.2024
9. Houston, we don't have a problem... with APOLLO

   Vom: 28.8.2024
10. From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment

    Vom: 13.6.2024
11. Episode 24: Myeloma Madness with the Myeloma Man

    Vom: 17.4.2024
12. Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

    Vom: 25.1.2024
13. LymphOMG: Pouring Over Lymphoma Abstracts from ASH

    Vom: 29.12.2023
14. AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy

    Vom: 19.12.2023
15. ASH Pregaming - Myeloma Madness with Manni and Papa Heme

    Vom: 1.12.2023
16. AML Maintenance Part 2: a metaMORPHOsis?

    Vom: 8.11.2023
17. AML Maintenance Part 1: Set Your QUAZARs to Stun

    Vom: 25.10.2023
18. Episode 17: The Hemophilia Eras Tour

    Vom: 23.8.2023
19. Common Sense Oncology: Outcomes That Matter

    Vom: 1.8.2023
20. All too well: the reality of leukemia treatment

    Vom: 8.6.2023